Open : Lymphoma Risk and Overall Safety Profile of Adalimumab in Patients With Crohn's Disease With up to 6 Years of Follow-up in the PYRAMID Registry
D'Haens G., Reinisch W., Panaccione R., Satsangi J., Petersson J., Bereswill M., Arikan D., Perotti E., Robinson AM., Kalabic J., Alperovich G., Thakkar R., Loftus EV.